Nomenclature
CAS number: 72496-41-4
(8
S,10
S)-10-[[3-Amino-2,3,6-trideoxy-4-
O-[(2
S)-tetrahydro-2
H-pyran-2-yl]-α-
l-
lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; 4′-
O-tetrahydropyranyl doxorubicin; (2″
R)-4′-
O-tetrahydropyranyladriamycin; tepirubicin; THP; THP-ADM; THP-adriamycin; 1609-RB; Theprubicin (Aventis).
C
32H
37NO
12; mol wt 627.64.
C 61.24%, H 5.94%, N 2.23%, O 30.59%.
Description and references
Structural analog of doxorubicin, q.v. Prepn of (2″R) and (2″S)-diastereomers: H. Umezawa et al., J. Antibiot. 32, 1082
(1979); idem et al., EP 14853; eidem, US 4303785 (1980, 1981 both to Microbiochem. Res. Found. Japan). Absolute configuration:
idem et al., J. Antibiot. 37, 1094 (1984). HPLC determn in biological fluids:
Y. Matsushita et al., ibid. 36, 880
(1983). Cellular uptake and inhibition of DNA synthesis: S. Kunimoto et al., ibid. 312 (1983). Mechanism of action study:
K.-I. Kiyomiya et al., Int. J.
Oncol. 21, 1081 (2002). Clinical pharmacokinetics
and toxicity: A. A. Miller, C. G. Schmidt, Cancer Res. 47, 1461 (1987). Overview of
clinical experience: H. Majima, K. Ohta, Biomed. Pharmacother. 41, 237-243 (1987).
Clinical evaluation in metastatic colon cancer: D. Fallik et
al., Ann. Oncol. 14, 856 (2003)
Properties
Red solid, mp 188-192° (dec). [α]D25 +175 ±25° (c = 0.2 in CHCl3). uv and visible max (methanol):
234, 252, 290, 498, 531.5, 580 nm (E1%1cm 480, 350, 110,
140, 100, 45). Sol in ethyl acetate, chloroform, and ethanol;
slightly sol in water, n-hexane, petr ether. Ethanolic
and acidic solutions are red in color; give a positive ninhydrin reaction
and do not reduce Fehling's solution. LD50 i.v. in mice: 27.8 mg/kg (Umezawa, 1979).Derivative
Hydrochloride.
Nomenclature
CAS number: 95343-20-7
Pinorubin (Nippon Kayaku); Therarubicin (Meiji Seika).
C
32H
37NO
12.HCl; mol wt 664.10.
C 57.87%, H 5.77%, N 2.11%, O 28.91%, Cl 5.34%.
Properties
Red crystalline solid. Sol in water and methanol.Therapeutic Category
Antineoplastic.
Keywords
Antineoplastic; Antibiotics and Analogs; Anthracyclines; Topoisomerase II Inhibitor